Fodosine is a potent, orally active purine nucleoside phosphorylase (PNP) inhibitor primarily investigated for the treatment of T-cell malignancies and various lymphoid disorders. By inhibiting the PNP… Read more
Fodosine is a potent, orally active purine nucleoside phosphorylase (PNP) inhibitor primarily investigated for the treatment of T-cell malignancies and various lymphoid disorders. By inhibiting the PNP enzyme, this compound modulates the purine salvage pathway to induce apoptosis in malignant cells, making it a subject of significant pharmacological interest. This category provides essential tools for rigorous scientific analysis, offering high-quality reference standards of the Fodosine API, as well as its related impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for laboratories performing impurity profiling, method validation, and routine quality control to ensure the accuracy and reliability of analytical results. By utilizing these precise reference materials, researchers can effectively monitor compound stability and verify testing protocols throughout the development and manufacturing processes of pharmaceutical products.